The positive effect of plasma cell–targeted treatment in our patient supports the involvement of monoclonal gammopathy in the pathophysiology of AAE-C1INH, even in the absence of C1INH-specific antibodies. The gene discussed is SERPING1; the disease is acquired angioedema.